AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|
30.5 C
New York
Monday, June 29, 2026

Tag: conference

newssourceFORcompanyinformationcontent1releasesmarket

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Bragar Eagel & Squire, P.C. Reminds Investors in IRobot (IRBT) of the Class Action Lawsuit and Encourages Investors to Inquire About Their Rights

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses IRobot (IRBT) To Contact Him Directly To Discuss Their Options

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

UPDATE: Slide to Report Second Quarter 2025 Results on Tuesday, August 12, 2025

TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) today announced it will release its second quarter 2025 financial results after the stock market closes on Tuesday, August 12, 2025.

Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight

No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic...

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. SECOND QUARTER 2025 RESULTS

MEXICO CITY, July 28, 2025 /PRNewswire/ -- Grupo Comercial Chedraui, S.A.B. de C.V. reports its 2025 second quarter results. All figures are shown in...

Paramount Global to Report Second Quarter 2025 Financial Results on July 31, 2025

NEW YORK, July 28, 2025 /PRNewswire/ -- Paramount Global (NASDAQ: PARA, PARAA) announced today that it will report second quarter 2025 financial results on...

Avionté Announces Passing of Chief Executive Officer Rishabh Mehrotra; Mike Metzger Appointed as Interim CEO

Company to Honor Leader's Legacy at CONNECT 2025 Conference Next Week BLOOMINGTON, Minn., July 28, 2025 /PRNewswire/ -- Avionté, a leader in enterprise staffing and...

In Celebration of Tony Bennett’s Birthday, CARNEGIE HALL+ Announces the Streaming Premiere of BECAUSE OF YOU, Michael Feinstein’s Concert Tribute to Tony Bennett, Beginning...

Special streaming premiere of performance featuring the Carnegie Hall Big Band, filmed on tour at Segerstrom Center for the Arts, available for the first...

TOPAZ REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS DEMONSTRATING STRONG ROYALTY AND INFRASTRUCTURE GROWTH

CALGARY, AB, July 28, 2025 /CNW/ - Topaz Energy Corp. (TSX: TPZ) ("Topaz" or the "Company") is pleased to provide second quarter 2025 financial...

Fluence Energy, Inc. Announces Third Quarter 2025 Earnings Release Date, Conference Call and Webcast

ARLINGTON, Va., July 28, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), announced today that it will report earnings for the third quarter ended June 30th, 2025 on Monday, August 11th, 2025, after market close.

Legacy Housing Corporation Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

BEDFORD, Texas, July 28, 2025 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (“Legacy” or the “Company”, NASDAQ: LEGH) will release its financial results for the second quarter ended June 30, 2025, after markets close on Thursday, August 7, 2025. The Company will then host a conference call at 10:00 a.m. Central Time on Friday, August 8, 2025.

PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

- Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older - - PTC will host a conference call on...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsConference

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers